Emerging Markets
- Emerging Markets
UPOV Updates Explanatory Note on Essentially Derived Varieties (EDVs)...
UPOV Updates Explanatory Note on Essentially Derived Varieties (EDVs) In October 2023, the International Union for the Protection of New Varieties of Plants (UPOV)…
- Emerging Markets
Update February 2024 on Commission Plans Liberalization of New Genomic...
Update February 2024 on Commission Plans Liberalization of New Genomic Techniques (NGTS) in the EU By: Wolfgang Schönig and Liz Freeman Rosenzweig Ph.D. Research…
- Emerging Markets
New Plants, Old Frameworks: FDA’s 1992 Policy Applies to Foods...
New Plants, Old Frameworks: FDA’s 1992 Policy Applies to Foods Derived from Genome-Edited Plants On February 22, 2024, FDA released a final guidance[1] detailing how foods…
- Emerging Markets
Biopharma Industry’s Resilience: A Year of Revival and Growth...
In a narrative that began with adversity, the biopharma sector has navigated through challenges to emerge with vigor and resilience, marking a year of…
- Emerging Markets
Roche’s Xolair Shows Promise in Reducing Severe Food Allergies, Earns...
Published February 26, 2023 A groundbreaking study presented at the American Academy of Allergy, Asthma & Immunology meeting revealed promising results for Roche’s Xolair…
- Emerging Markets
These Pharmaceutical Giants Are Revolutionizing Cancer Treatment with Nuclear Medicine...
Published February 27, 2024 Big pharmaceutical players are making significant investments in nuclear medicine, reshaping the landscape of cancer treatment with targeted approaches. With…